Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Lynparza granted Priority Review in the US for BRCA-mutated HER2-negative high-risk early breast cancer
-
AstraZeneca unveils The Discovery Centre (DISC) in Cambridge
-
New analyses of two AZD7442 COVID-19 Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
-
Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world less than 12 months after first approval
-
AZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
-
Year-to-date and Q3 2021 results
-
AstraZeneca advances ambition to redefine care for blood cancer at ASH 2021
-
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
-
Imfinzi plus chemotherapy significantly improved overall survival in 1st-line advanced biliary tract cancer in TOPAZ-1 Phase III trial at interim analysis
-
Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial in 1st-line unresectable liver cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
